Download now: Cannabis Cash

This Is Warren Buffett’s Greatest Regret

Written by Keith Kohl
Posted September 29, 2021

Close your eyes for a moment and imagine what $100 billion would look like on your bank statement. 

Go ahead, I’ll wait.

That’s what Warren Buffett’s net worth looks like right now.

Thing is, he’s pissed it isn’t much, MUCH higher.

Despite his illustrious career in the market, Buffett lives his life with one huge pang of regret each night when his head hits the pillow — one born out of pure jealousy.

Even after amassing that kind of vast wealth, he still doesn’t crack Forbes' list of the top-five richest people in the world. 

It’s true, the Oracle of Omaha does hold an immense grudge against someone.

But their last name isn’t Zuckerberg, Gates, Musk, or Bezos.

Care to take a guess who could live rent-free in the mind of the greatest investor of our times? 

It’s you. 

And the reason why could make you filthy rich.

Warren Buffett’s Great Regret and Why It’s Worth Billions to You

At the tender age of 91, the Oracle of Omaha is easily considered one of the most respected and prosperous investors in history. 

And his performance speaks for itself. 

Since 1965, Berkshire's average annual return of 20% has doubled the S&P 500's performance over the same period.

Don’t get me wrong — posting roughly 20% per year for more than 50 years is an incredible feat. 

Buffett's portfolio is a virtual who’s who of today's biggest players in the market. 

By the age of 33, his net worth had climbed to over $1 million.

By 55, he netted his first billion. 

You know just as well as I do that he wasn’t content with just $1 billion, and his fortune swelled over the next few decades to over $100 billion this year.

So you’re probably wondering why Warren Buffett is actually envious of investors like us. 

Years ago, Buffett boasted that he could post annual profits of over 50% each year if he were allowed to play by the same rules as you.

But there’s one huge catch…

In order to achieve this enormous return every year, he would have to do it with less than $1 million. 

That’s right. 

Warren Buffett is handcuffed by the wealth he’s built over his lifetime.

The curse of his fortune is that he HAS to put his money in mammoth companies like Apple, Bank of America, and Coco-Cola Co. 

But while those massive companies have performed well for him over his investing career, Buffett yearns for the freedom to really put his money to work.

That, dear reader, is the advantage you hold over Warren Buffett. 

You just need to know how to use it.

How to Beat Buffett at His Own Game

Although his portfolio is a list of the largest companies on the planet, Buffett has lamented in the past that he would prefer to bank his money on small caps. 

He once quipped, “We can’t put many billions to work every year in spectacular business. To move the needle at Berkshire, they have to be big transactions.”

When COVID-19 started wreaking havoc on the global economy last year, Buffett did what he does best: He bought stocks.

It’s no surprise that he started to go heavy on Big Pharma, taking positions in Merck, Bristol Myers Squibb, and Pfizer, just to name a few.

However, the incredible profits he’s made during the COVID pandemic must’ve been painful, because every dollar he spent on those large corporations could’ve meant 10 times the value if he were able to really let loose.

Like I said, his hands are tied.

Yours aren’t.

More importantly, neither are the hands of my colleague Jeff Siegel

Unlike Buffett, Jeff and his readers have been capitalizing time and again off the same stocks Buffett dreams of buying at night. 

This morning, I figured out exactly how he does it. 

By targeting a special back-door trading strategy that targets those highly sought-after small biotech companies, Jeff and his readers are beating the market 4 out of every 5 trades they make.

Don’t think it’s possible?

Stay tuned, because tomorrow morning he’s going to tell you precisely how they’re doing it. 

I strongly recommend you check this one out for yourself.

Until next time,

Keith Kohl Signature

Keith Kohl

follow basic@KeithKohl1 on Twitter

A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing's Energy Investor and Technology and Opportunity.

For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.

Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.

Hydrogen Fuel Cells: The Downfall of Tesla?